🇺🇸 Entecavir dispersible tablets in United States
8 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 8
Most-reported reactions
- Drug Eruption — 2 reports (25%)
- Pruritus — 2 reports (25%)
- Purpura — 2 reports (25%)
- Urine Output Decreased — 2 reports (25%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Entecavir dispersible tablets approved in United States?
Entecavir dispersible tablets does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Entecavir dispersible tablets in United States?
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.